Back
Stoke Therapeutics Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
19
STOK
Stoke Therapeutics
Last Price:
$7.58
Seasonality Move:
-2.4%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Stoke Therapeutics Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 2.4% based on the past 5 years of stock performance.
-
Stoke Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Stoke Therapeutics Stock Undervalued?The current Stoke Therapeutics [STOK] share price is $7.02. The Score for STOK is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
STOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 2.4% based on the past 5 years of stock performance.
Stoke Therapeutics Stock Rating
Sell
19
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics overpriced?
-
Stoke Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Stoke Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
17.58
52-Week Low:
5.35
Prediction Charts
Market Cap:
379.6M
Price in USD:
7.02
Volume:
731.1K
Beta:
0.93
Technical Analysis
SMA50:
8.63
SMA100:
9.97
SMA200:
11.81
52-Wk Change:
-48%
Stock Predictions
-
Is Stoke Therapeutics stock public?Yes, Stoke Therapeutics is a publicly traded company.
-
What is the Stoke Therapeutics stock quote today?The Stoke Therapeutics stock price is 7.02 USD today.
-
How to buy Stoke Therapeutics stock online?You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-25 | 8.27 | 7.74 | 8.34 | 7.52 |
| Mar-26 | 7.74 | 7.40 | 7.74 | 7.18 |
| Mar-27 | 7.43 | 7.45 | 7.56 | 7.29 |
| Mar-28 | 7.45 | 7.21 | 7.48 | 7.06 |
| Mar-31 | 7.00 | 6.65 | 7.08 | 6.60 |
| Apr-1 | 6.59 | 6.23 | 6.73 | 6.10 |
| Apr-2 | 6.16 | 6.60 | 6.66 | 6.14 |
| Apr-3 | 6.22 | 6.30 | 6.44 | 6.00 |
| Apr-4 | 6.07 | 5.94 | 6.20 | 5.66 |
| Apr-7 | 5.68 | 6.01 | 6.17 | 5.45 |
| Apr-8 | 6.25 | 5.90 | 6.34 | 5.71 |
| Apr-9 | 5.76 | 6.43 | 6.47 | 5.35 |
| Apr-10 | 6.23 | 6.52 | 6.55 | 5.94 |
| Apr-11 | 6.51 | 7.02 | 7.13 | 6.42 |
Stoke Therapeutics Earnings
Stoke Therapeutics Earnings Report: Per Share Stoke Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics Forecast Revenue Growth
Stoke Therapeutics Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and a decrease next year of $0.84 per share.
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.